Enzyme Immunoassay Market Revenue to Attain USD 25.33 Bn by 2033
Published: 02 Dec 2025
Author: Precedence Research
Enzyme Immunoassay Market Revenue and Trends 2025 to 2033
The global enzyme immunoassay market revenue reached USD 18.51 billion in 2025 and is predicted to attain around USD 25.33 billion by 2033 with a CAGR of 4.00%. The market is expected to grow due to the rising prevalence of chronic diseases, resulting in a high volume of laboratory tests, an increasing number of sample tests, and a high demand for accurate test results to promptly identify major medical issues and receive the right treatment.
Key Highlights of Enzyme Immunoassay Market
- By region, North America led the enzyme immunoassay market in 2024, whereas the Asia Pacific is expected to grow in the foreseeable period.
- By product, the reagents and kits segment dominated the enzyme immunoassay market in 2024, whereas the software and services segment is expected to grow in the expected timeframe.
- By application, the infectious diseases testing segment led the enzyme immunoassay market in 2024, whereas the oncology segment is expected to grow in the foreseeable period.
- By specimen, the blood specimen segment led the enzyme immunoassay market in 2024, whereas the urine specimen segment is expected to grow in the foreseen period.
- By end use, the hospital segment led the enzyme immunoassay market in 2024, whereas the clinical laboratories segment is expected to grow in the foreseeable period.
Rising Chronic Diseases Aiding the Growth of Enzyme Immunoassay Industry
The enzyme immunoassay market is expected to grow due to rising prevalence of chronic diseases, increasing demand for precision medicine, and the need for accurate, precise results. Enzyme immunoassay is a widely utilized biochemical technique highly useful for clinical diagnostics, pharmaceuticals, and research applications. The market also observes growth due to the high efficiency and accuracy of the results provided by enzyme immunoassays. The market also observes growth driven by rising preventive healthcare and high demand for early detection of chronic diseases to enable timely and effective treatment, further fueling the market.
Highly Utilized Domains of Enzyme Immunoassays
- Clinical Diagnostics- the segment involves mass screening and diagnostics of infectious diseases such as HIV, Hepatitis B and C, Tuberculosis, Lyme Diseases, and Syphilis. The domain also involves identifying hormonal levels and tumor markers in the blood. The use of enzyme immunoassays for clinical diagnostics also helps to detect antibodies associated with autoimmune disorders and allergens in patients.
- Biomedical Research and Development- the segment highlights the importance of research for detecting and quantifying various biomolecules even in low concentrations. The segment focuses on in-depth studies of health conditions such as Alzheimer’s and cardiovascular issues.
- Food Safety and Agriculture: enzyme immunoassays are widely used to ensure food safety and agriculture. Such tests help detect bacterial, mould, and chemical residues in pesticides and herbicides, which is beneficial for the market's growth.
New Trends of Enzyme Immunoassay Market
- Higher demand for decentralized testing with rapid handheld devices for use in clinics, remote areas, and at home is a major factor for the growth of the market.
- Personalized treatments and medication leading to higher demand for personalized biomarkers are another major factor for the market’s growth.
- Use of technology for improved accuracy and quicker results is another major factor contributing to the growth of the market.
Market Scope
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 18.51 Billion |
| Market Revenue by 2033 | USD 25.33 Billion |
| CAGR from 2025 to 2033 | 4.00% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2024 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa |
Market Dynamics
Drivers
What Are the Growth Drivers of the Enzyme Immunoassay Market?
The rising prevalence of infectious and chronic diseases, leading to higher demand for preventive healthcare and various diagnostic tests, is a major growth driver for the market. Enzyme immunoassays help in the early detection of infectious and fatal diseases, such as HIV, cancer, diabetes, cardiovascular issues, and other similar health problems, further fueling the market's growth.
The market also observes growth due to an aging population that often experiences age-related health issues, further fueling market growth. Technological advancements, which help with early disease detection, provide accurate results, and suggest effective management methods, are also a major factor in the market's growth.
Challenge
Competition From Alternative Technologies Is Hampering the Market’s Growth
One of the major restraints on the market's growth is the adoption of other technologies for detecting fatal diseases. Molecular diagnostics, rapid diagnostics, and biosensors are other methods available in the market that may hamper its growth. Use of such methods also enables faster turnaround times, greater sensitivity, and lower costs, further driving market growth. Hence, such issues collectively restrain the market's growth.
Opportunity
Higher Demand for Personalized Medicine and Biomarker Discovery Is Helpful for the Market’s Growth
Higher demand for personalized medications for oncology and cardiovascular conditions is a major factor driving market growth. Timely detection of such issues, leading to higher demand for enzyme immunoassays and biomarkers for personalized treatment and drug options, also fuels market growth. Hence, these factors collectively help fuel the market's growth. The whole procedure helps create a curated medical treatment plan involving personalized treatment and drugs for quicker, more efficient recovery, which is helpful for the growth of the enzyme immunoassay industry.
Regional Insights
North America Dominated the Enzyme Immunoassay Market in 2024
North America led the enzyme immunoassay market in 2024, mainly due to advanced healthcare systems and facilities, growing investments in the field, higher research and development for the development of advanced techniques, and higher demand for precision medicine. The US has a major role in the market's growth due to technologically advanced healthcare facilities and systems that use enzyme immunoassays for early detection of infectious and chronic diseases, further fueling the market's growth in the region.
Asia Pacific Is Observed to Be the Fastest-Growing Region in the Foreseeable Period
Asia Pacific is expected to be the fastest-growing region over the forecast period due to major contributions from countries such as India, China, Japan, South Korea, and Singapore. The country's major medical names primarily invest in the healthcare domain, further fueling market growth in the foreseeable future. Advancing research and development, developing healthcare infrastructure, and government support for the medical domain are other major factors driving the market’s growth.
Europe Is Observed to Have a Notable Growth in the Foreseeable Period
Europe is expected to experience notable growth in the forecast period due to factors such as rising prevalence of infectious and chronic diseases, technological advancements in the medical domain, and higher demand for tests with accurate, faster results. Such factors collectively lead to higher demand for enzyme immunoassays and similar tests that enable early detection and accurate results, thereby fueling market growth. The UK and Germany play a major role in the region's market growth due to rising chronic diseases, higher demand for effective tests and results, and greater demand for precision medicine.
Segmental Insights
By Product Insights
The reagents and kits segment led the enzyme immunoassay market in 2024, driven by high demand across sectors such as clinical diagnostics, pharmaceutical analytics, and food safety testing. The market also shows growth due to high demand across various fields. The rise in chronic diseases has driven high demand for high-sensitivity tests and kits for routine testing and drug discovery. The segment also observes growth due to high demand for various consumables, including reagents, antibodies, substrates, and buffers, thereby maintaining segment demand.
The software and services segment is expected to grow over the foreseeable period due to high demand for accurate, reliable immunoassay test results, leading to the adoption of software and services by healthcare facilities and laboratories. The technological support helps ease the complex procedures involved in performing immunoassay tests, which is beneficial for the market's growth. Advanced algorithms and data analysis techniques, along with efficient data management systems, are among the segment's key strengths, further fueling market growth in the foreseeable period.
By Application Insights
The infectious diseases testing segment dominated the enzyme immunoassay market in 2024, driven by the rise of chronic diseases globally, which led to high demand for immunoassay tests for accurate, specific results. The market has observed growth since the pandemic, enabling the identification of any disease as quickly as possible. Public health initiatives and global health programs aimed at controlling the spread of infectious diseases use serological assays, including enzyme immunoassays, further fueling the market's growth. It aids disease screening and monitoring, further helping the market’s growth.
The oncology segment is expected to grow over the forecast period due to rising cases of various forms of cancer in recent years, leading to high demand for early detection to enable timely treatment. It also helps to lower the chances of fatal levels of cancer, to lower the death rate, further fueling the growth of the market in the foreseeable period. Use of enzyme immunoassays as the preferred method for detecting biomarkers associated with various cancer types also fuels market growth. The assays play a vital role in technological advancements and cost-effective EIA tests.
By Specimen Insights
The blood specimen segment led the enzyme immunoassay market in 2024, as blood-based enzyme immunoassays are sensitive and specific, making them well-suited for early detection of chronic and fatal diseases, further fueling the market's growth. It also helps serve as a broad-spectrum disease screening and monitoring tool for infections, chronic diseases, and hormonal imbalances, further fueling the market's growth. Hence, the segment makes a major contribution to market growth.
The urine specimen segment is expected to grow over the forecast period, as the specimen type is non-invasive, which is preferred by patients and healthcare providers alike and is helpful for market growth in the forecast period. It is also an easy form of management for routine checkups and screening, further fueling the market's growth in the foreseeable future. Urine-based enzyme immunoassay kits help deliver accurate, faster results for preventive healthcare, encouraging market growth in the foreseeable future. It also requires minimal tools and equipment, further fueling the market’s growth.
By End Use Insights
The hospital segment led the enzyme immunoassay market in 2024, as hospitals handle multiple cases and their associated specimens in various forms, leading to high utilization of enzyme immunoassays compared to other healthcare facilities. Hence, the segment plays a major role in the market's growth. The form of testing helps provide accurate and efficient results in less time, which is helpful for patient care and management, further fueling the market's growth. Higher demand for enzyme immunoassays for effective, timely results, early detection of chronic diseases, and operational efficiency in developed countries is another major factor driving the market's growth.
The clinical laboratories segment is expected to grow over the forecast period due to the prevalence of infectious and chronic diseases, leading to high demand for diagnostic tests involving enzyme immunoassays, which will help fuel market growth. Enzyme immunoassays help in early detection and provide accurate results, further aiding the market’s growth. It further helps healthcare centers and patients manage health conditions efficiently and at the right time. The rising expansion of preventive healthcare, driven by rising infections, lifestyle-related health issues, and other problems, also helps fuel the market's growth in the foreseeable period.
Top Companies of Enzyme Immunoassay Market
- Siemens Healthineers
- Danaher Corporation (Beckman Coulter)
- bioMérieux SA
- QuidelOrtho Corporation.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Becton, Dickinson, and Company
- Thermo Fisher Scientific, Inc.
Recent Developments in the Enzyme Immunoassay Market
- In May 2025, Revvity Inc. announced the launch of its new IDS i20, an analytical random access platform from EUROIMMUN. The platform enables full automation of chemiluminescence immunoassays (ChLIA). The instruments allow users to run 20 analytes from six diagnostic specialties on a single device. (Source- https://www.biospectrumindia.com)
- In September 2025, Fujirebio announced the availability of the Lumipulse G sTREAM assay for the fully automated LUMIPULSE G immunoassay analyzers.
Segments Covered in the Report
By Product
- Reagents & Kits
- Analyzers/Instruments
- Software & Services
By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
By Specimen
- Blood
- Saliva
- Urine
- Other Specimens
By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)